1.Leonard JM, Toro DD. Defining the Microbiome Components (Bacteria, Viruses, Fungi) and Microbiome Geodiversity. Surgical infections. 2023;24(3):208-12.
2.Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists. Cancer research. 2017;77(8):1783-812.
3.Eloe-Fadrosh EA, Rasko DA. The human microbiome: from symbiosis to pathogenesis. Annual review of medicine. 2013;64:145-63.
4.Wang B, Wang L, Wang H, Dai H, Lu X, Lee Y-k, et al. Targeting the Gut Microbiota for Remediating Obesity and Related Metabolic Disorders. The Journal of Nutrition. 2021;151(7):1703-16.
5.Aggarwal N, Kitano S, Puah GRY, Kittelmann S, Hwang IY, Chang MW. Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies. Chemical reviews. 2023;123(1):31-72.
6.Hou K, Wu Z-X, Chen X-Y, Wang J-Q, Zhang D, Xiao C, et al. Microbiota in health and diseases. Signal Transduction and Targeted Therapy. 2022;7(1):135.
7.Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7(1):135.
8.Zhao Ma, Chu J, Feng S, Guo C, Xue B, He K, et al. Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review. Biomedicine & Pharmacotherapy. 2023;164:114985.
9.Shen Y, Fan N, Ma SX, Cheng X, Yang X, Wang G. Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy. MedComm. 2025;6(5):e70168.
10.Metwaly A, Kriaa A, Hassani Z, Carraturo F, Druart C, Trebicka J, et al. A Consensus Statement on establishing causality, therapeutic applications and the use of preclinical models in microbiome research. Nature Reviews Gastroenterology & Hepatology. 2025;22(5):343-56.
11.Schupack DA, Mars RAT, Voelker DH, Abeykoon JP, Kashyap PC. The promise of the gut microbiome as part of individualized treatment strategies. Nature reviews Gastroenterology & hepatology. 2022;19(1):7-25.
12.Shukla V, Singh S, Verma S, Verma S, Rizvi AA, Abbas M. Targeting the microbiome to improve human health with the approach of personalized medicine: Latest aspects and current updates. Clinical Nutrition ESPEN. 2024;63:813-20.
13.Rodríguez JM, Murphy K, Stanton C, Ross RP, Kober OI, Juge N, et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microbial ecology in health and disease. 2015;26:26050.
14.Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Research. 2020;30(6):492-506.
15.Bemark M, Pitcher MJ, Dionisi C, Spencer J. Gut-associated lymphoid tissue: a microbiota-driven hub of B cell immunity. Trends in immunology. 2024;45(3):211-23.
16.Dieterich W, Schink M, Zopf Y. Microbiota in the Gastrointestinal Tract. Medical sciences (Basel, Switzerland). 2018;6(4).
17.Pandiyan P, Bhaskaran N, Zou M, Schneider E, Jayaraman S, Huehn J. Microbiome Dependent Regulation of Tregs and Th17 Cells in Mucosa. 2019;Volume 10 - 2019.
18.Shin Y, Han S, Kwon J, Ju S, Choi TG, Kang I, et al. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease. Nutrients. 2023;15(20).
19.Mostafavi Abdolmaleky H, Zhou J-R. Gut Microbiota Dysbiosis, Oxidative Stress, Inflammation, and Epigenetic Alterations in Metabolic Diseases. Antioxidants [Internet]. 2024; 13(8).
20.Toor D, Wsson MK, Kumar P, Karthikeyan G, Kaushik NK, Goel C, et al. Dysbiosis Disrupts Gut Immune Homeostasis and Promotes Gastric Diseases. Int J Mol Sci. 2019;20(10).
21.Dogra SK, Kwong Chung C, Wang D, Sakwinska O, Colombo Mottaz S, Sprenger N. Nurturing the Early Life Gut Microbiome and Immune Maturation for Long Term Health. Microorganisms. 2021;9(10).
22.Gaufin T, Tobin NH, Aldrovandi GM. The importance of the microbiome in pediatrics and pediatric infectious diseases. Current opinion in pediatrics. 2018;30(1):117-24.
23.Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121-41.
24.Luczynski P, McVey Neufeld KA, Oriach CS, Clarke G, Dinan TG, Cryan JF. Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior. The international journal of neuropsychopharmacology. 2016;19(8).
25.Bos A, van Egmond M, Mebius R. The role of retinoic acid in the production of immunoglobulin A. Mucosal Immunology. 2022;15(4):562-72.
26.Kogut MH, Lee A, Santin E. Microbiome and pathogen interaction with the immune system. Poultry Science. 2020;99(4):1906-13.
27.Li Z, Xiong W, Liang Z, Wang J, Zeng Z, Kołat D, et al. Critical role of the gut microbiota in immune responses and cancer immunotherapy. Journal of hematology & oncology. 2024;17(1):33.
28.Nazir A, Hussain FHN, Nadeem Hussain TH, Al Dweik R, Raza A. Therapeutic targeting of the host-microbiota-immune axis: implications for precision health. 2025;Volume 16 - 2025.
29.Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30(6):492-506.
30.Thomson CA, Morgan SC, Ohland C, McCoy KD. From germ-free to wild: modulating microbiome complexity to understand mucosal immunology. Mucosal Immunology. 2022;15(6):1085-94.
31.Zhang H, Yang Lee BJ, Wang T, Xiang X, Tan Y, Han Y, et al. Microbiota, chronic inflammation, and health: The promise of inflammatome and inflammatomics for precision medicine and healthcare. hLife. 2025.
32.Mousa WK, Chehadeh F, Husband S. Microbial dysbiosis in the gut drives systemic autoimmune diseases. Frontiers in immunology. 2022;13:906258.
33.Shim JA, Ryu JH, Jo Y, Hong C. The role of gut microbiota in T cell immunity and immune mediated disorders. International journal of biological sciences. 2023;19(4):1178-91.
34.Kang X, Lau HC, Yu J. Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy. Cell reports Medicine. 2024;5(4):101478.
35.Zhang M, Liu J, Xia Q. Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target. Experimental hematology & oncology. 2023;12(1):84.
36.Kim SK, Cho SW. The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment. Frontiers in pharmacology. 2022;13:868695.
37.Yousefi Y, Baines KJ, Maleki Vareki S. Microbiome bacterial influencers of host immunity and response to immunotherapy. Cell reports Medicine. 2024;5(4):101487.
38.Marciscano AE, Anandasabapathy N. The role of dendritic cells in cancer and anti-tumor immunity. Seminars in immunology. 2021;52:101481.
39.Jiang S, Ma W, Ma C, Zhang Z, Zhang W, Zhang J. An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome. Gut microbes. 2024;16(1):2341717.
40.Xie J, Liu M, Deng X, Tang Y, Zheng S, Ou X, et al. Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies. iMeta. 2024;3(1):e156.
41.Kamel M, Aleya S, Alsubih M, Aleya L. Microbiome Dynamics: A Paradigm Shift in Combatting Infectious Diseases. Journal of personalized medicine. 2024;14(2).
42.Chang SH, Choi Y. Gut dysbiosis in autoimmune diseases: Association with mortality. Frontiers in cellular and infection microbiology. 2023;13:1157918.
43.Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR, Scaldaferri F. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Internal and emergency medicine. 2024;19(2):275-93.
44.Tian H, Wang X, Fang Z, Li L, Wu C, Bi D, et al. Fecal microbiota transplantation in clinical practice: Present controversies and future prospects. hLife. 2024;2(6):269-83.
45.Sahle Z, Engidaye G, Shenkute Gebreyes D, Adenew B, Abebe TA. Fecal microbiota transplantation and next-generation therapies: A review on targeting dysbiosis in metabolic disorders and beyond. SAGE open medicine. 2024;12:20503121241257486.
46.Mafe AN, Büsselberg D. Modulation of the Neuro–Cancer Connection by Metabolites of Gut Microbiota. Biomolecules [Internet]. 2025; 15(2).
47.Wu HJ, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut microbes. 2012;3(1):4-14.
48.Zhang Y, Chen R, Zhang D, Qi S, Liu Y. Metabolite interactions between host and microbiota during health and disease: Which feeds the other? Biomedicine & Pharmacotherapy. 2023;160:114295.
49.Wu J, Wang K, Wang X, Pang Y, Jiang C. The role of the gut microbiome and its metabolites in metabolic diseases. Protein & cell. 2021;12(5):360-73.
50.Liu J, Tan Y, Cheng H, Zhang D, Feng W, Peng C. Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives. Aging and disease. 2022;13(4):1106-26.
51.He J, Zhang P, Shen L, Niu L, Tan Y, Chen L, et al. Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism. Int J Mol Sci. 2020;21(17).
52.Silva YP, Bernardi A, Frozza RL. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Frontiers in endocrinology. 2020;11:25.
53.Masse KE, Lu VB. Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease. Frontiers in endocrinology. 2023;14:1169624.
54.Devaraj S, Hemarajata P, Versalovic J. The human gut microbiome and body metabolism: implications for obesity and diabetes. Clinical chemistry. 2013;59(4):617-28.
55.de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71(5):1020-32.
56.Sanmiguel C, Gupta A, Mayer EA. Gut Microbiome and Obesity: A Plausible Explanation for Obesity. Current obesity reports. 2015;4(2):250-61.
57.Peña-Durán E, García-Galindo JJ, López-Murillo LD, Huerta-Huerta A, Balleza-Alejandri LR, Beltrán-Ramírez A, et al. Microbiota and Inflammatory Markers: A Review of Their Interplay, Clinical Implications, and Metabolic Disorders. International Journal of Molecular Sciences [Internet]. 2025; 26(4).
58.Jennison E, Byrne CD. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease. Clinical and molecular hepatology. 2021;27(1):22-43.
59.Abenavoli L, Scarlata GGM, Scarpellini E, Boccuto L, Spagnuolo R, Tilocca B, et al. Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome. Medicina (Kaunas, Lithuania). 2023;59(3).
60.Yuan H, Wu X, Wang X, Zhou J-Y, Park S. Microbial Dysbiosis Linked to Metabolic Dysfunction-Associated Fatty Liver Disease in Asians: Prevotella copri Promotes Lipopolysaccharide Biosynthesis and Network Instability in the Prevotella Enterotype. International Journal of Molecular Sciences [Internet]. 2024; 25(4).
61.Bandopadhyay P, Ganguly D. Chapter Six - Gut dysbiosis and metabolic diseases. In: Das B, Singh V, editors. Progress in Molecular Biology and Translational Science. 191: Academic Press; 2022. p. 153-74.
62.Ma ZF, Lee YY. The Role of the Gut Microbiota in Health, Diet, and Disease with a Focus on Obesity. Foods [Internet]. 2025; 14(3).
63.Geng J, Ni Q, Sun W, Li L, Feng X. The links between gut microbiota and obesity and obesity related diseases. Biomedicine & Pharmacotherapy. 2022;147:112678.
64.Zsálig D, Berta A, Tóth V, Szabó Z, Simon K, Figler M, et al. A Review of the Relationship between Gut Microbiome and Obesity. Applied Sciences [Internet]. 2023; 13(1).
65.Pant K, Venugopal SK, Lorenzo Pisarello MJ, Gradilone SA. The Role of Gut Microbiome-Derived Short-Chain Fatty Acid Butyrate in Hepatobiliary Diseases. The American Journal of Pathology. 2023;193(10):1455-67.
66.Silva YP, Bernardi A, Frozza RL. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. 2020;Volume 11 - 2020.
67.Du Y, He C, An Y, Huang Y, Zhang H, Fu W, et al. The Role of Short Chain Fatty Acids in Inflammation and Body Health. International Journal of Molecular Sciences [Internet]. 2024; 25(13).
68.Chao J, Coleman RA, Keating DJ, Martin AM. Gut Microbiome Regulation of Gut Hormone Secretion. Endocrinology. 2025;166(4).
69.Cavallari JF, Schertzer JD. Intestinal Microbiota Contributes to Energy Balance, Metabolic Inflammation, and Insulin Resistance in Obesity. Journal of obesity & metabolic syndrome. 2017;26(3):161-71.
70.Yang W, Cong Y. Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases. Cellular & molecular immunology. 2021;18(4):866-77.
71.Byndloss M, Devkota S, Duca F, Niess JH, Nieuwdorp M, Orho-Melander M, et al. The gut microbiota and diabetes: research, translation, and clinical applications - 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum. Diabetologia. 2024;67(9):1760-82.
72.Zhang K, Zhang Q, Qiu H, Ma Y, Hou N, Zhang J, et al. The complex link between the gut microbiome and obesity-associated metabolic disorders: Mechanisms and therapeutic opportunities. Heliyon. 2024;10(17):e37609.
73.Shan L, Tyagi A, Shabbir U, Chen X, Vijayalakshmi S, Yan P, et al. The Role of Gut Microbiota Modulation Strategies in Obesity: The Applications and Mechanisms. Fermentation [Internet]. 2022; 8(8).
74.O'Riordan KJ, Collins MK, Moloney GM, Knox EG, Aburto MR, Fülling C, et al. Short chain fatty acids: Microbial metabolites for gut-brain axis signalling. Molecular and Cellular Endocrinology. 2022;546:111572.
75.Zhao X, An X, Yang C, Sun W, Ji H, Lian F. The crucial role and mechanism of insulin resistance in metabolic disease. 2023;Volume 14 - 2023.
76.Szymczak-Pajor I, Drzewoski J, Kozłowska M, Krekora J, Śliwińska A. The Gut Microbiota-Related Antihyperglycemic Effect of Metformin. Pharmaceuticals [Internet]. 2025; 18(1).
77.Salamone D, Rivellese AA, Vetrani C. The relationship between gut microbiota, short-chain fatty acids and type 2 diabetes mellitus: the possible role of dietary fibre. Acta diabetologica. 2021;58(9):1131-8.
78.Sivaprakasam S, Prasad PD, Singh N. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. Pharmacology & therapeutics. 2016;164:144-51.
79.Liu J, Li F, Yang L, Luo S, Deng Y. Gut microbiota and its metabolites regulate insulin resistance: traditional Chinese medicine insights for T2DM. Frontiers in microbiology. 2025;16:1554189.
80.Shen Y, Fan N, Ma S-x, Cheng X, Yang X, Wang G. Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy. 2025;6(5):e70168.
81.Singh R, Zogg H, Wei L, Bartlett A, Ghoshal UC, Rajender S, et al. Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders. Journal of neurogastroenterology and motility. 2021;27(1):19-34.
82.Patra D, Banerjee D, Ramprasad P, Roy S, Pal D, Dasgupta S. Recent insights of obesity-induced gut and adipose tissue dysbiosis in type 2 diabetes. Frontiers in molecular biosciences. 2023;10:1224982.
83.da Silva Rosa SC, Nayak N, Caymo AM, Gordon JW. Mechanisms of muscle insulin resistance and the cross-talk with liver and adipose tissue. Physiological reports. 2020;8(19):e14607.
84.Nogal A, Valdes AM, Menni C. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut microbes. 2021;13(1):1-24.
85.Lopez-Pedrosa JM, Camprubi-Robles M, Guzman-Rolo G, Lopez-Gonzalez A, Garcia-Almeida JM, Sanz-Paris A, et al. The Vicious Cycle of Type 2 Diabetes Mellitus and Skeletal Muscle Atrophy: Clinical, Biochemical, and Nutritional Bases. Nutrients. 2024;16(1).
86.Beltrán-Velasco AI, Clemente-Suárez VJ. Harnessing Gut Microbiota for Biomimetic Innovations in Health and Biotechnology. Biomimetics (Basel, Switzerland). 2025;10(2).
87.Singh RK, Chang HW, Yan D, Lee KM, Ucmak D, Wong K, et al. Influence of diet on the gut microbiome and implications for human health. Journal of translational medicine. 2017;15(1):73.
88.Ji J, Jin W, Liu SJ, Jiao Z, Li X. Probiotics, prebiotics, and postbiotics in health and disease. MedComm. 2023;4(6):e420.
89.Gao Y, Li W, Huang X, Lyu Y, Yue C. Advances in Gut Microbiota-Targeted Therapeutics for Metabolic Syndrome. Microorganisms. 2024;12(5).
90.Hrncir T. Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options. Microorganisms. 2022;10(3).
91.Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism: clinical and experimental. 2022;133:155217.
92.Saad MJA, Santos A. The Microbiota and Evolution of Obesity. Endocrine Reviews. 2024;46(2):300-16.
93.Davis CD. The Gut Microbiome and Its Role in Obesity. Nutrition today. 2016;51(4):167-74.
94.Kalnina I, Gudra D, Silamikelis I, Viksne K, Roga A, Skinderskis E, et al. Variations in the Relative Abundance of Gut Bacteria Correlate with Lipid Profiles in Healthy Adults. Microorganisms. 2023;11(11).
95.Gomes AC, Hoffmann C, Mota JF. The human gut microbiota: Metabolism and perspective in obesity. Gut microbes. 2018;9(4):308-25.
96.Moran-Ramos S, López-Contreras BE, Canizales-Quinteros S. Gut Microbiota in Obesity and Metabolic Abnormalities: A Matter of Composition or Functionality? Archives of Medical Research. 2017;48(8):735-53.
97.Staley C, Weingarden AR, Khoruts A, Sadowsky MJ. Interaction of gut microbiota with bile acid metabolism and its influence on disease states. Applied microbiology and biotechnology. 2017;101(1):47-64.
98.Enache R-M, Profir M, Roşu OA, Creţoiu SM, Gaspar BS. The Role of Gut Microbiota in the Onset and Progression of Obesity and Associated Comorbidities. International Journal of Molecular Sciences [Internet]. 2024; 25(22).
99.Hemachandra S, Rathnayake SN, Jayamaha AA, Francis BS, Welmillage D, Kaur DN, et al. Fecal Microbiota Transplantation as an Alternative Method in the Treatment of Obesity. Cureus. 2025;17(1):e76858.
100.Mederle AL, Dima M, Stoicescu ER, Căpăstraru BF, Levai CM, Hațegan OA, et al. Impact of Gut Microbiome Interventions on Glucose and Lipid Metabolism in Metabolic Diseases: A Systematic Review and Meta-Analysis. Life [Internet]. 2024; 14(11).
101.Zhang Z, Mocanu V, Cai C, Dang J, Slater L, Deehan EC, et al. Impact of Fecal Microbiota Transplantation on Obesity and Metabolic Syndrome-A Systematic Review. Nutrients. 2019;11(10).
102.Horvath A, Zukauskaite K, Hazia O, Balazs I, Stadlbauer V. Human gut microbiome: Therapeutic opportunities for metabolic syndrome—Hype or hope? 2024;7(1):e436.
103.Chandrasekaran P, Weiskirchen S, Weiskirchen R. Effects of Probiotics on Gut Microbiota: An Overview. Int J Mol Sci. 2024;25(11).
104.Peckmezian T, Garcia-Larsen V, Wilkins K, Mosli RH, BinDhim NF, John GK, et al. Microbiome-Targeted Therapies as an Adjunct to Traditional Weight Loss Interventions: A Systematic Review and Meta-Analysis. Diabetes, metabolic syndrome and obesity : targets and therapy. 2022;15:3777-98.
105.Napolitano M, Covasa M. Microbiota Transplant in the Treatment of Obesity and Diabetes: Current and Future Perspectives. Frontiers in microbiology. 2020;11:590370.
106.Mathur S, Sutton J. Personalized medicine could transform healthcare. Biomedical reports. 2017;7(1):3-5.
107.Yaqub MO, Jain A, Joseph CE, Edison LK. Microbiome-Driven Therapeutics: From Gut Health to Precision Medicine. Gastrointestinal Disorders [Internet]. 2025; 7(1).
108.Noecker C, McNally CP, Eng A, Borenstein E. High-resolution characterization of the human microbiome. Translational research : the journal of laboratory and clinical medicine. 2017;179:7-23.
109.Hemmati MA, Monemi M, Asli S, Mohammadi S, Foroozanmehr B, Haghmorad D, et al. Using New Technologies to Analyze Gut Microbiota and Predict Cancer Risk. Cells. 2024;13(23).
110.Gulliver EL, Young RB, Chonwerawong M, D'Adamo GL, Thomason T, Widdop JT, et al. Review article: the future of microbiome-based therapeutics. Alimentary pharmacology & therapeutics. 2022;56(2):192-208.
111.Liu Y, Li X, Chen Y, Yao Q, Zhou J, Wang X, et al. Fecal microbiota transplantation: application scenarios, efficacy prediction, and factors impacting donor-recipient interplay. Frontiers in microbiology. 2025;16:1556827.
112.Abeltino A, Hatem D, Serantoni C, Riente A, De Giulio MM, De Spirito M, et al. Unraveling the Gut Microbiota: Implications for Precision Nutrition and Personalized Medicine. Nutrients [Internet]. 2024; 16(22).
113.Rouskas K, Guela M, Pantoura M, Pagkalos I, Hassapidou M, Lalama E, et al. The Influence of an AI-Driven Personalized Nutrition Program on the Human Gut Microbiome and Its Health Implications. Nutrients [Internet]. 2025; 17(7).
114.Mafe AN, Büsselberg D. Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug. Biomedicines [Internet]. 2025; 13(2).
115.Rodriguez J, Cordaillat-Simmons M, Pot B, Druart C. The regulatory framework for microbiome-based therapies: insights into European regulatory developments. npj Biofilms and Microbiomes. 2025;11(1):53.
116.Han D, Gao P, Li R, Tan P, Xie J, Zhang R, et al. Multicenter assessment of microbial community profiling using 16S rRNA gene sequencing and shotgun metagenomic sequencing. Journal of Advanced Research. 2020;26:111-21.
117.Pérez-Bustamante IS, Cruz-Flores R, López-Carvallo JA, Sánchez-Serrano S. Effect of the 16S rRNA Gene Hypervariable Region on the Microbiome Taxonomic Profile and Diversity in the Endangered Fish Totoaba macdonaldi. Microorganisms [Internet]. 2024; 12(11).
118.Bekele GK, Abda EM, Tuji FA, Meka AF, Gemeda MT. Shotgun Metagenomics Reveals Metabolic Potential and Functional Diversity of Microbial Communities of Chitu and Shala Soda Lakes in Ethiopia. Microbiology Research [Internet]. 2025; 16(3).
119.Lee D, Maaskant A, Ngo H, Montijn RC, Bakker J, Langermans JAM, et al. A rapid, affordable, and reliable method for profiling microbiome biomarkers from fecal images. iScience. 2024;27(12).
120.Babu M, Snyder M. Multi-Omics Profiling for Health. Molecular & cellular proteomics : MCP. 2023;22(6):100561.
121.Bars-Cortina D, Ramon E, Rius-Sansalvador B, Guinó E, Garcia-Serrano A, Mach N, et al. Comparison between 16S rRNA and shotgun sequencing in colorectal cancer, advanced colorectal lesions, and healthy human gut microbiota. BMC Genomics. 2024;25(1):730.
122.Oudat Q, Okour A. The Role of Probiotics in Modulating Gut Microbiota and Metabolic Health for Weight Management: A Mini Review. Acta Microbiologica Hellenica [Internet]. 2025; 70(1).
123.D’Urso F, Broccolo F. Applications of Artificial Intelligence in Microbiome Analysis and Probiotic Interventions—An Overview and Perspective Based on the Current State of the Art. Applied Sciences [Internet]. 2024; 14(19).
124.Kim CH. Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity. Cellular & molecular immunology. 2023;20(4):341-50.
125.Mincic AM, Antal M, Filip L, Miere D. Modulation of gut microbiome in the treatment of neurodegenerative diseases: A systematic review. Clinical Nutrition. 2024;43(7):1832-49.
126.Wang S, Xiao Y, Tian F, Zhao J, Zhang H, Zhai Q, et al. Rational use of prebiotics for gut microbiota alterations: Specific bacterial phylotypes and related mechanisms. Journal of Functional Foods. 2020;66:103838.
127.Rozera T, Pasolli E, Segata N, Ianiro G. Machine Learning and Artificial Intelligence in the Multi-Omics Approach to Gut Microbiota. Gastroenterology. 2025.
128.Zhang P. Influence of Foods and Nutrition on the Gut Microbiome and Implications for Intestinal Health. Int J Mol Sci. 2022;23(17).
129.Aziz T, Hussain N, Hameed Z, Lin L. Elucidating the role of diet in maintaining gut health to reduce the risk of obesity, cardiovascular and other age-related inflammatory diseases: recent challenges and future recommendations. Gut microbes. 2024;16(1):2297864.
130.Bianchetti G, De Maio F, Abeltino A, Serantoni C, Riente A, Santarelli G, et al. Unraveling the Gut Microbiome-Diet Connection: Exploring the Impact of Digital Precision and Personalized Nutrition on Microbiota Composition and Host Physiology. Nutrients. 2023;15(18).
131.Rinninella E, Tohumcu E, Raoul P, Fiorani M, Cintoni M, Mele MC, et al. The role of diet in shaping human gut microbiota. Best Practice & Research Clinical Gastroenterology. 2023;62-63:101828.
132.Hills RD, Jr., Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR. Gut Microbiome: Profound Implications for Diet and Disease. Nutrients. 2019;11(7).
133.Hernández-Calderón P, Wiedemann L, Benítez-Páez A. The microbiota composition drives personalized nutrition: Gut microbes as predictive biomarkers for the success of weight loss diets. Frontiers in nutrition. 2022;9:1006747.
134.Rondinella D, Raoul PC, Valeriani E, Venturini I, Cintoni M, Severino A, et al. The Detrimental Impact of Ultra-Processed Foods on the Human Gut Microbiome and Gut Barrier. Nutrients [Internet]. 2025; 17(5).
135.Markowiak P, Śliżewska K. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients. 2017;9(9).
136.Yasmin A, Butt MS, Afzaal M, van Baak M, Nadeem MT, Shahid MZ. Prebiotics, gut microbiota and metabolic risks: Unveiling the relationship. Journal of Functional Foods. 2015;17:189-201.
137.Mafe AN, Edo GI, Majeed OS, Gaaz TS, Akpoghelie PO, Isoje EF, et al. A review on probiotics and dietary bioactives: Insights on metabolic well-being, gut microbiota, and inflammatory responses. Food Chemistry Advances. 2025;6:100919.
138.Jiang S, Huang S, Zhang Z, Ma W, Han Z, Song Y, et al. Gut microbiota drives structural variation of exogenous probiotics to enhance colonization. Gut microbes. 2025;17(1):2503371.
139.O’Riordan KJ, Moloney GM, Keane L, Clarke G, Cryan JF. The gut microbiota-immune-brain axis: Therapeutic implications. Cell Reports Medicine. 2025;6(3):101982.
140.O'Riordan KJ, Moloney GM, Keane L, Clarke G, Cryan JF. The gut microbiota-immune-brain axis: Therapeutic implications. Cell reports Medicine. 2025;6(3):101982.